The Role Rapid Acceleration of Diagnostics Tech Continues to Play in the Covid-19 Pandemic and Next Steps - CIMIT MAIN
CIMIT is a network of world-class academic and medical institutions partnering with industry and government. Our mission is to foster collaboration among clinicians, technologists, and entrepreneurs to accelerate innovation and catalyze the discovery, development, and implementation of innovative healthcare technologies.
Initiatives and Funding Opportunities
Latest News
The Role Rapid Acceleration of Diagnostics Tech Continues to Play in the Covid-19 Pandemic and Next Steps
The Role Rapid Acceleration of Diagnostics Tech Continues to Play in the Covid-19 Pandemic and Next Steps
Rapid Acceleration of Diagnostics (RADx) Tech is a National Institutes of Health (NIH)-funded program launched on 29 April 2020, to accelerate commercialization of novel lab-based, point-of-care, and home-based tests to diagnose infection with SARS-CoV-2, the virus that causes COVID-19. RADx Tech was implemented and coordinated by the Consortia for Improving Medicine with Innovation & Technology (CIMIT) in its role as the Coordinating Center for the Point-of-Care Technologies Research Network (POCTRN) in conjunction with the NIH’s National Institute of Biomedical Imaging and Bioengineering (NIBIB) and the four POCTRN Centers.
Read the full article in the Expert Review of Molecular Diagnostics >